Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
N/A
-377,460 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
N/A
198,400 Added 110.8%
377,460 $796,000
Q1 2021

May 13, 2021

BUY
N/A
179,060 New
179,060 $517,000
Q3 2020

Nov 13, 2020

SELL
N/A
-104,045 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
N/A
47,715 Added 84.71%
104,045 $669,000
Q1 2020

May 14, 2020

SELL
N/A
-35,315 Reduced 38.53%
56,330 $234,000
Q4 2019

Feb 13, 2020

BUY
N/A
55,441 Added 153.14%
91,645 $542,000
Q3 2019

Nov 13, 2019

SELL
N/A
-31,615 Reduced 46.62%
36,204 $196,000
Q2 2019

Aug 12, 2019

SELL
N/A
-56,345 Reduced 45.38%
67,819 $547,000
Q1 2019

May 14, 2019

BUY
N/A
88,445 Added 247.61%
124,164 $983,000
Q4 2018

Feb 13, 2019

BUY
N/A
35,719 New
35,719 $156,000

About Catabasis Pharmaceuticals, Inc.


  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.